Live-Action “Beauty and the Beast” Prequel Series About LeFou and Gaston in Development for Disney+; Luke Evans and Josh Gad to Reprise Roles

It has been reported by The Hollywood Reporter that a prequel spin-off series to the 2017 live-action “Beauty and the Beast” is currently in development.

“Beauty and the Beast”, 2017

To make this news even more exciting, it has been confirmed that the series will star Luke Evans and Josh Gad, reprising their roles as Gaston and LeFou. While no further information has been released regarding storylines or setting, just the thought of having LeFou and Gaston in a series is enough to sell us. Will it be the story of how the best buds met? Will it document what Gaston was like when he only ate four dozen eggs every morning? Will we find out what LeFou’s real name is (because I refuse to believe anyone’s parents are that harsh)? The possibilities are endless. We’re very excited.

Evans and Gad in the 2017 live-action “Beauty and the Beast”

The series is currently in the early development stages, but has been confirmed for Disney+. It will be a six-part musical series, with Eddy Kitsis and Adam Horowitz co-writing, along with Josh Gad himself. While no other stars are currently reported as attached to the movie, such as Emma Watson or Dan Stevens, Alan Menken is in talks to return to compose the score.

My, what a guy!

We’re very excited for this new addition to Disney+. If, like me, you’re based in Western Europe, don’t forget you can now pre-register for the streaming service, which is due to go live on March 24! Plus, if you’re a fan of LeFou, make sure you check out the recently-opened Beauty and the Beast Sing-Along show in EPCOT, where it’s the sidekick himself who is the star of the show.

For more information on booking your next trip with our official travel agent sponsor, the Vacationeer, visit

0 0 votes
Article Rating
Newest Most Voted
Inline Feedbacks
View all comments
1 year ago

Sounds unnecessary and skippable

Impressions de Frank
Impressions de Frank
1 year ago

First, the coronavirus. And now this.